Predictors for Chronic Urinary Toxicity After the Treatment of Prostate Cancer With Adaptive Three-Dimensional Conformal Radiotherapy: Dose–Volume Analysis of a Phase II Dose-Escalation Study
Predictors for Chronic Urinary Toxicity After the Treatment of Prostate Cancer With Adaptive Three-Dimensional Conformal Radiotherapy: Dose–Volume Analysis of a Phase II Dose-Escalation Study is a paper indexed in PICO Portal from OpenAlex.
How many citations does Predictors for Chronic Urinary Toxicity After the Treatment of Prostate Cancer With Adaptive Three-Dimensional Conformal Radiotherapy: Dose–Volume Analysis of a Phase II Dose-Escalation Study have?
Predictors for Chronic Urinary Toxicity After the Treatment of Prostate Cancer With Adaptive Three-Dimensional Conformal Radiotherapy: Dose–Volume Analysis of a Phase II Dose-Escalation Study has 100 citations in the OpenAlex counts PICO Portal stores.
When was Predictors for Chronic Urinary Toxicity After the Treatment of Prostate Cancer With Adaptive Three-Dimensional Conformal Radiotherapy: Dose–Volume Analysis of a Phase II Dose-Escalation Study published?
Predictors for Chronic Urinary Toxicity After the Treatment of Prostate Cancer With Adaptive Three-Dimensional Conformal Radiotherapy: Dose–Volume Analysis of a Phase II Dose-Escalation Study has 2007 year in the PICO Portal index.
What is the open-access status of Predictors for Chronic Urinary Toxicity After the Treatment of Prostate Cancer With Adaptive Three-Dimensional Conformal Radiotherapy: Dose–Volume Analysis of a Phase II Dose-Escalation Study?
Predictors for Chronic Urinary Toxicity After the Treatment of Prostate Cancer With Adaptive Three-Dimensional Conformal Radiotherapy: Dose–Volume Analysis of a Phase II Dose-Escalation Study has closed oa status in the PICO Portal index.
What is the DOI of Predictors for Chronic Urinary Toxicity After the Treatment of Prostate Cancer With Adaptive Three-Dimensional Conformal Radiotherapy: Dose–Volume Analysis of a Phase II Dose-Escalation Study?
The DOI for Predictors for Chronic Urinary Toxicity After the Treatment of Prostate Cancer With Adaptive Three-Dimensional Conformal Radiotherapy: Dose–Volume Analysis of a Phase II Dose-Escalation Study is on the source record.
What is the PMID of Predictors for Chronic Urinary Toxicity After the Treatment of Prostate Cancer With Adaptive Three-Dimensional Conformal Radiotherapy: Dose–Volume Analysis of a Phase II Dose-Escalation Study?
The PMID for Predictors for Chronic Urinary Toxicity After the Treatment of Prostate Cancer With Adaptive Three-Dimensional Conformal Radiotherapy: Dose–Volume Analysis of a Phase II Dose-Escalation Study is on the source record.
What is the OpenAlex record for Predictors for Chronic Urinary Toxicity After the Treatment of Prostate Cancer With Adaptive Three-Dimensional Conformal Radiotherapy: Dose–Volume Analysis of a Phase II Dose-Escalation Study?
The OpenAlex for Predictors for Chronic Urinary Toxicity After the Treatment of Prostate Cancer With Adaptive Three-Dimensional Conformal Radiotherapy: Dose–Volume Analysis of a Phase II Dose-Escalation Study is on the source record.